Aclaris Therapeutics Statistics
Total Valuation
ACRS has a market cap or net worth of $544.86 million. The enterprise value is $395.61 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACRS has 139.00 million shares outstanding. The number of shares has increased by 58.56% in one year.
| Current Share Class | 139.00M |
| Shares Outstanding | 139.00M |
| Shares Change (YoY) | +58.56% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 43.72% |
| Float | 95.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 69.62 |
| Forward PS | 110.03 |
| PB Ratio | 4.56 |
| P/TBV Ratio | 5.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 50.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.36 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.20% and return on invested capital (ROIC) is -35.16%.
| Return on Equity (ROE) | -50.20% |
| Return on Assets (ROA) | -24.32% |
| Return on Invested Capital (ROIC) | -35.16% |
| Return on Capital Employed (ROCE) | -56.20% |
| Weighted Average Cost of Capital (WACC) | 7.95% |
| Revenue Per Employee | $107,205 |
| Profits Per Employee | -$889,356 |
| Employee Count | 73 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +240.87% in the last 52 weeks. The beta is 0.68, so ACRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +240.87% |
| 50-Day Moving Average | 3.52 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 55.46 |
| Average Volume (20 Days) | 1,665,457 |
Short Selling Information
The latest short interest is 7.02 million, so 5.05% of the outstanding shares have been sold short.
| Short Interest | 7.02M |
| Short Previous Month | 4.70M |
| Short % of Shares Out | 5.05% |
| Short % of Float | 7.33% |
| Short Ratio (days to cover) | 1.84 |
Income Statement
In the last 12 months, ACRS had revenue of $7.83 million and -$64.92 million in losses. Loss per share was -$0.53.
| Revenue | 7.83M |
| Gross Profit | -52.10M |
| Operating Income | -74.08M |
| Pretax Income | -64.92M |
| Net Income | -64.92M |
| EBITDA | -74.04M |
| EBIT | -74.08M |
| Loss Per Share | -$0.53 |
Full Income StatementBalance Sheet
The company has $90.75 million in cash and $2.12 million in debt, with a net cash position of $149.25 million or $1.07 per share.
| Cash & Cash Equivalents | 90.75M |
| Total Debt | 2.12M |
| Net Cash | 149.25M |
| Net Cash Per Share | $1.07 |
| Equity (Book Value) | 103.08M |
| Book Value Per Share | 0.86 |
| Working Capital | 67.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.11 million and capital expenditures -$111,000, giving a free cash flow of -$47.22 million.
| Operating Cash Flow | -47.11M |
| Capital Expenditures | -111,000 |
| Depreciation & Amortization | 40,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -47.22M |
| FCF Per Share | -$0.34 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -946.52% |
| Pretax Margin | -829.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.56% |
| Shareholder Yield | -58.56% |
| Earnings Yield | -11.92% |
| FCF Yield | -8.67% |
Analyst Forecast
The average price target for ACRS is $9.75, which is 148.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.75 |
| Price Target Difference | 148.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 76.17% |
| EPS Growth Forecast (5Y) | -2.68% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -7.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.22 |
| Piotroski F-Score | 1 |
